+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Women's Health Diagnostics Market Research Report by Type (Point-of-care and Self Check), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 239 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4829897
UP TO OFF until Dec 31st 2022
The Global Women’s Health Diagnostics Market size was estimated at USD 37.07 billion in 2021, USD 40.34 billion in 2022, and is projected to grow at a CAGR 9.00% to reach USD 62.18 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Women’s Health Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Point-of-care and Self Check.
  • Based on Application, the market was studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests. The Breast Cancer Testing is further studied across Biopsies, Blood Chemistries and Blood Cell Count Tests, Breast Cancer Tumor Marker Tests, and Mammography. The Cervical Cancer Testing is further studied across HPV Testing and PAP Smear. The Infectious Disease Testing is further studied across HEPAtitis Testing, MRSA Testing, Tuberculosis Testing, and Urinary Tract Infection Testing (Vaginal Ph & Vaginitis). The Osteoporosis Testing is further studied across Bone Densitometry and in Vitro Blood Tests. The Ovarian Cancer Testing is further studied across Diagnostic Imaging Tests and Ovarian Cancer Tumor Marker Tests. The Pregnancy and Fertility Testing is further studied across Fertility Monitors, Lab-Based Testing, and Pregnancy Testing and Ovulation Prediction Kits. The Prenatal Genetic Screening and Carrier Testing is further studied across Cystic Fibrosis, Down Syndrome and Edwards Syndrome, and Torch Infections. The Sexually Transmitted Disease Testing is further studied across Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing and HIV Testing. The Ultrasound Tests is further studied across Breast Imaging and OB/GYN Imaging.
  • Based on End User, the market was studied across Diagnostic and Imaging Centers, Home Care, and Hospitals and Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Women’s Health Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Women’s Health Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Women’s Health Diagnostics Market, including Abbott Laboratories, AccuBioTech Co., Ltd., Alere Inc., Becton, Dickinson and Company, Biomérieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc., Cook Medical, Inc., Danaher Corporation, DIALAB GmbH, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Guided Therapeutics, Inc., Hologic, Inc., Koninklijke Philips N.V., MedGyn Products, Inc., NeuroLogica Corporation, Nova Biomedical, Osteometer MediTech, Inc., Perkinelmer Inc., Quest Diagnostics Incorporated, Siemens AG, SuperSonic Imagine, and WerfenLife, S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Women’s Health Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women’s Health Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women’s Health Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Women’s Health Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Women’s Health Diagnostics Market?
6. What is the market share of the leading vendors in the Global Women’s Health Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Women’s Health Diagnostics Market?
Frequently Asked Questions about the Global Women’s Health Diagnostics Market

What is the estimated value of the Global Women’s Health Diagnostics Market?

The Global Women’s Health Diagnostics Market was estimated to be valued at $37.07 Billion in 2021.

What is the growth rate of the Global Women’s Health Diagnostics Market?

The growth rate of the Global Women’s Health Diagnostics Market is 9.0%, with an estimated value of $62.18 Billion by 2027.

What is the forecasted size of the Global Women’s Health Diagnostics Market?

The Global Women’s Health Diagnostics Market is estimated to be worth $62.18 Billion by 2027.

Who are the key companies in the Global Women’s Health Diagnostics Market?

Key companies in the Global Women’s Health Diagnostics Market include Abbott Laboratories, AccuBioTech Co., Ltd., Alere Inc., Becton, Dickinson and Company, Biomérieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc. and Danaher Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Instances of Chronic and Life Style- Related Disorders in Women
5.1.1.2. Awareness About Fertility Testing in Women Coupled with Initiatives Taken by Health Organizations and Government
5.1.1.3. Adoption of Point-Of-Care and Rapid Diagnostic Tests
5.1.1.4. Availability of Imaging and Private Diagnostic Centres
5.1.1.5. Ppp to Develop the Modern Infrastructure of Diagnostic Imaging Centres
5.1.2. Restraints
5.1.2.1. Limited Technically Skilled Lab Assistants
5.1.3. Opportunities
5.1.3.1. Improved and Technically Advanced Healthcare Infrastructure in Emerging Economies
5.1.3.2. Regulatory Approvals for Immunoassay Diagnostics Techniques
5.1.3.3. Growing Focus on Microfluidics and Nanotechnology-Based Poc Devices for Diagnostic
5.1.3.4. Clinical Trial Assessment for the Diagnosis of Breast Cancer
5.1.4. Challenges
5.1.4.1. High Cost Associated with Procedures and Diagnostic Imaging Systems
5.1.4.2. Stringent Regulatory Guidelines
5.2. Cumulative Impact of COVID-19
6. Women's Health Diagnostics Market, by Type
6.1. Introduction
6.2. Point-Of-Care
6.3. Self Check
7. Women's Health Diagnostics Market, by Application
7.1. Introduction
7.2. Breast Cancer Testing
7.2.1. Biopsies
7.2.2. Blood Chemistries and Blood Cell Count Tests
7.2.3. Breast Cancer Tumor Marker Tests
7.2.4. Mammography
7.3. Cervical Cancer Testing
7.3.1. Hpv Testing
7.3.2. Pap Smear
7.4. Infectious Disease Testing
7.4.1. Hepatitis Testing
7.4.2. Mrsa Testing
7.4.3. Tuberculosis Testing
7.4.4. Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
7.5. Osteoporosis Testing
7.5.1. Bone Densitometry
7.5.2. in Vitro Blood Tests
7.6. Ovarian Cancer Testing
7.6.1. Diagnostic Imaging Tests
7.6.2. Ovarian Cancer Tumor Marker Tests
7.7. Pregnancy and Fertility Testing
7.7.1. Fertility Monitors
7.7.2. Lab-Based Testing
7.7.3. Pregnancy Testing and Ovulation Prediction Kits
7.8. Prenatal Genetic Screening and Carrier Testing
7.8.1. Cystic Fibrosis
7.8.2. Down Syndrome and Edwards Syndrome
7.8.3. Torch Infections
7.9. Sexually Transmitted Disease Testing
7.9.1. Chlamydia Trachomatis and Neisseria Gonorrhoeae (Ct/Ng) Testing
7.9.2. Hiv Testing
7.10. Ultrasound Tests
7.10.1. Breast Imaging
7.10.2. Ob/Gyn Imaging
8. Women's Health Diagnostics Market, by End-user
8.1. Introduction
8.2. Diagnostic and Imaging Centers
8.3. Home Care
8.4. Hospitals and Clinics
9. Americas Women's Health Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Women's Health Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Women's Health Diagnostics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Accubiotech Co., Ltd.
13.3. Alere Inc.
13.4. Becton, Dickinson and Company
13.5. Biomérieux Sa
13.6. Cardinal Health, Inc.
13.7. Carestream Health, Inc.
13.8. Chembio Diagnostic Systems, Inc.
13.9. Cook Medical, Inc.
13.10. Danaher Corporation
13.11. Dialab GmbH
13.12. Ekf Diagnostics Holdings plc
13.13. F. Hoffmann-La Roche Ltd.
13.14. Fujifilm Holdings Corporation
13.15. GE Healthcare
13.16. Guided Therapeutics, Inc.
13.17. Hologic, Inc.
13.18. Koninklijke Philips N.V.
13.19. Medgyn Products, Inc.
13.20. Neurologica Corporation
13.21. Nova Biomedical
13.22. Osteometer Meditech, Inc.
13.23. Perkinelmer Inc.
13.24. Quest Diagnostics Incorporated
13.25. Siemens Ag
13.26. Supersonic Imagine
13.27. Werfenlife, S.A.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET DYNAMICS
FIGURE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2027
FIGURE 18. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), 2019-2027 (USD BILLION)
FIGURE 43. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 44. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2019-2027 (USD BILLION)
FIGURE 45. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, 2019-2027 (USD BILLION)
FIGURE 47. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 48. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, 2019-2027 (USD BILLION)
FIGURE 49. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 50. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2019-2027 (USD BILLION)
FIGURE 51. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 52. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, 2019-2027 (USD BILLION)
FIGURE 53. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 54. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, 2019-2027 (USD BILLION)
FIGURE 55. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 56. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, 2019-2027 (USD BILLION)
FIGURE 57. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 58. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, 2019-2027 (USD BILLION)
FIGURE 59. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 60. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, 2019-2027 (USD BILLION)
FIGURE 61. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 62. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, 2019-2027 (USD BILLION)
FIGURE 63. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 64. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, 2019-2027 (USD BILLION)
FIGURE 65. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 66. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, 2019-2027 (USD BILLION)
FIGURE 67. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 68. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, 2019-2027 (USD BILLION)
FIGURE 69. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 70. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, 2019-2027 (USD BILLION)
FIGURE 71. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 72. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2019-2027 (USD BILLION)
FIGURE 73. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 74. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, 2019-2027 (USD BILLION)
FIGURE 75. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 76. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, 2019-2027 (USD BILLION)
FIGURE 77. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 78. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2019-2027 (USD BILLION)
FIGURE 79. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 80. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, 2019-2027 (USD BILLION)
FIGURE 81. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 82. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, 2019-2027 (USD BILLION)
FIGURE 83. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 84. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 85. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 86. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2027
FIGURE 87. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, 2019-2027 (USD BILLION)
FIGURE 88. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 89. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2019-2027 (USD BILLION)
FIGURE 90. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 91. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2019-2027 (USD BILLION)
FIGURE 92. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 93. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 94. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 95. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 96. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 97. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 98. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 99. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 100. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 101. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 102. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 103. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 104. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2027
FIGURE 105. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 106. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 107. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 108. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 109. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 110. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 111. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 112. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 113. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 114. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 115. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 116. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 117. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 118. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 119. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 120. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 121. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 122. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 123. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2027
FIGURE 124. FRANCE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 125. GERMANY WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 126. ITALY WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 127. NETHERLANDS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 128. QATAR WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 129. RUSSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 130. SAUDI ARABIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 131. SOUTH AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 132. SPAIN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 133. UNITED ARAB EMIRATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 134. UNITED KINGDOM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 135. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 136. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 137. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 17. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 18. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 20. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 30. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 35. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 48. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 50. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY REGION, 2019-2027 (USD BILLION)
TABLE 53. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY STATE, 2019-2027 (USD BILLION)
TABLE 55. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 58. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 60. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 63. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 70. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 73. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY REGION, 2019-2027 (USD BILLION)
TABLE 78. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY STATE, 2019-2027 (USD BILLION)
TABLE 80. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 83. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY REGION, 2019-2027 (USD BILLION)
TABLE 88. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY STATE, 2019-2027 (USD BILLION)
TABLE 90. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 92. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 93. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 95. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 97. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 98. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 99. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 100. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 102. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 103. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 104. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 105. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 107. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 108. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 109. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 110. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 112. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 113. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 114. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 115. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 117. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2019-2027 (USD BILLION)
TABLE 118. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 119. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY STATE, 2019-2027 (USD BILLION)
TABLE 120. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 122. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 123. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 124. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 125. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 127. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY REGION, 2019-2027 (USD BILLION)
TABLE 128. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 129. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY STATE, 2019-2027 (USD BILLION)
TABLE 130. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 132. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 133. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 134. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 135. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 137. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 138. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 139. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 140. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 142. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY REGION, 2019-2027 (USD BILLION)
TABLE 143. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 144. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY STATE, 2019-2027 (USD BILLION)
TABLE 145. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 147. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 148. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 149. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 150. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 152. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 153. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 154. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 155. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 157. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 158. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 159. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 160. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 162. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY REGION, 2019-2027 (USD BILLION)
TABLE 163. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 164. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY STATE, 2019-2027 (USD BILLION)
TABLE 165. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 167. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 168. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 169. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 170. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 172. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2019-2027 (USD BILLION)
TABLE 173. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 174. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY STATE, 2019-2027 (USD BILLION)
TABLE 175. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 177. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY REGION, 2019-2027 (USD BILLION)
TABLE 178. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 179. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY STATE, 2019-2027 (USD BILLION)
TABLE 180. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 182. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 183. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 184. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 185. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 186. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 188. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2019-2027 (USD BILLION)
TABLE 189. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 190. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY STATE, 2019-2027 (USD BILLION)
TABLE 191. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 193. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 194. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 195. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 196. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 198. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 199. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 200. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 201. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 202. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 203. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 204. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 205. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 206. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 207. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 208. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 209. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 210. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 211. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 212. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 213. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 214. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 215. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 216. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 217. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 218. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 219. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 220. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 221. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 222. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 223. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 224. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 225. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 226. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 227. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 228. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 229. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 230. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 231. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 232. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 233. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 234. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 235. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 236. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 237. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 238. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 239. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 240. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 241. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 242. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 243. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 244. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 245. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 246. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 247. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 248. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 249. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 250. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 251. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 252. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 253. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 254. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 255. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 256. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 257. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 258. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 259. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 260. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 261. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 262. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 263. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 264. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 265. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 266. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 267. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 268. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 269. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 270. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 271. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 272. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 278. FRANCE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 279. FRANCE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE,

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Alere Inc.
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Guided Therapeutics, Inc.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MedGyn Products, Inc.
  • NeuroLogica Corporation
  • Nova Biomedical
  • Osteometer MediTech, Inc.
  • Perkinelmer Inc.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • SuperSonic Imagine
  • WerfenLife, S.A.

Methodology

Loading
LOADING...